These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38609257)

  • 21. Programmable RNA detection with CRISPR-Cas12a.
    Rananaware SR; Vesco EK; Shoemaker GM; Anekar SS; Sandoval LSW; Meister KS; Macaluso NC; Nguyen LT; Jain PK
    bioRxiv; 2023 Jan; ():. PubMed ID: 36778248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Multifunctional CRISPR-Cas12a.
    Tian Z; Yan H; Zeng Y
    ACS Appl Mater Interfaces; 2024 Mar; 16(12):14445-14456. PubMed ID: 38472096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Trans-Cleavage Activity of CRISPR/Cas12a on Gold Nanoparticles for Stable and Sensitive Biosensing.
    Fu X; Shi Y; Peng F; Zhou M; Yin Y; Tan Y; Chen M; Yin X; Ke G; Zhang XB
    Anal Chem; 2021 Mar; 93(11):4967-4974. PubMed ID: 33703873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR-Cas12a Biosensor Array for Ultrasensitive Detection of Unamplified DNA with Single-Nucleotide Polymorphic Discrimination.
    Weng Z; You Z; Li H; Wu G; Song Y; Sun H; Fradlin A; Neal-Harris C; Lin M; Gao X; Zhang Y
    ACS Sens; 2023 Apr; 8(4):1489-1499. PubMed ID: 37027291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "RESET" Effect: Random Extending Sequences Enhance the Trans-Cleavage Activity of CRISPR/Cas12a.
    Ma JY; Wang SY; Du YC; Wang DX; Tang AN; Wang J; Kong DM
    Anal Chem; 2022 Jun; 94(22):8050-8057. PubMed ID: 35615910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensing platform for nucleic-acid detection based on a 2-aminopurine probe sheared by trans-cleavage activity of the CRISPR/Cas12a system.
    Chen X; Huang C; Hu Q; Zhang J; Wang D; You Q; Hu M
    Analyst; 2023 May; 148(11):2482-2492. PubMed ID: 37159025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing noncanonical crRNAs to improve functionality of Cas12a orthologs.
    Nguyen LT; Macaluso NC; Rakestraw NR; Carman DR; Pizzano BLM; Hautamaki RC; Rananaware SR; Roberts IE; Jain PK
    Cell Rep; 2024 Feb; 43(2):113777. PubMed ID: 38358883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets.
    Nalefski EA; Kooistra RM; Parikh I; Hedley S; Rajaraman K; Madan D
    Nucleic Acids Res; 2024 May; 52(8):4502-4522. PubMed ID: 38477377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement and inactivation effect of CRISPR/Cas12a via extending hairpin activators for detection of transcription factors.
    Jiang Y; Qian X; Zheng M; Deng K; Li C
    Mikrochim Acta; 2023 Dec; 191(1):43. PubMed ID: 38114763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual and colorimetric detection of microRNA in clinical samples based on strand displacement amplification and nanozyme-mediated CRISPR-Cas12a system.
    Luo B; Zhou J; Zhan X; Ying B; Lan F; Wu Y
    Talanta; 2024 Sep; 277():126310. PubMed ID: 38815319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer assisted CRISPR-Cas12a strategy for small molecule diagnostics.
    Niu C; Wang C; Li F; Zheng X; Xing X; Zhang C
    Biosens Bioelectron; 2021 Jul; 183():113196. PubMed ID: 33839534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized protocols for the characterization of Cas12a activities.
    Martin L; Rostami S; Rajan R
    Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A universal CRISPR/Cas12a nucleic acid sensing platform based on proximity extension and transcription-unleashed self-supply crRNA.
    Tian G; Zhang D; Wang Y; Hu T; Lin Y; Wang Y; Cheng W; Xia Q
    Anal Chim Acta; 2021 Sep; 1176():338755. PubMed ID: 34399899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A programmable and sensitive CRISPR/Cas12a-based MicroRNA detection platform combined with hybridization chain reaction.
    Jia HY; Zhao HL; Wang T; Chen PR; Yin BC; Ye BC
    Biosens Bioelectron; 2022 Sep; 211():114382. PubMed ID: 35605545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-canonical CRISPR/Cas12a-based technology: A novel horizon for biosensing in nucleic acid detection.
    Lei X; Cao S; Liu T; Wu Y; Yu S
    Talanta; 2024 May; 271():125663. PubMed ID: 38232570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas12a Coupled with DNA Nanosheet-Amplified Fluorescence Anisotropy for Sensitive Detection of Biomolecules.
    Xie TJ; Xie JL; Luo YJ; Mao K; Huang CZ; Li YF; Zhen SJ
    Anal Chem; 2023 May; 95(18):7237-7243. PubMed ID: 37120835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas12a-coupled multiplexed strand displacement amplification for miRNA155 one-tube detection: via a dual-cavity PCR tube.
    He X; Deng L; Zhou S; Dong J; Zhu S; Li J; Li X; Huo D; Hou C
    Mikrochim Acta; 2024 Jul; 191(8):470. PubMed ID: 39023769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmable CRISPR-Cas12a and self-recruiting crRNA assisted dual biosensing platform for simultaneous detection of lung cancer biomarkers hOGG1 and FEN1.
    Cheng X; Xia X; Ren D; Chen Q; Xu G; Wei F; Yang J; Wang L; Hu Q; Zou J; Cen Y
    Anal Chim Acta; 2023 Feb; 1240():340748. PubMed ID: 36641157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas12a-mediated DNA-AgNC label-free logical gate for multiple microRNAs' assay.
    Mu X; Li J; Xiao S; Huang Y; Zhao S; Tian J
    Mikrochim Acta; 2024 Jun; 191(7):376. PubMed ID: 38849560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
    Swarts DC; Jinek M
    Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.